about
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchImproving the quality and efficiency of follow-up after curative treatment for breast cancer--rationale and study design of the MaCare trial.Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States.Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survivalEstrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study.Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer ConsortiumRole of compression stockings after endovenous laser therapy for primary varicosis.Comparison of the diagnostic workup of women referred at non-blinded or blinded double reading in a population-based screening mammography programme in the south of the Netherlands.Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.Breast cancer survival in the US and Europe: a CONCORD high-resolution study.The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium.Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands.Re-attendance after false-positive screening mammography: a population-based study in the Netherlands.The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an example.Characteristics and screening outcome of women referred twice at screening mammography.Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature.Re-attendance at biennial screening mammography following a repeated false positive recall.Inconsistent selection and definition of local and regional endpoints in breast cancer research.Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study.The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. A systematic review of the literature.Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers.Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status.Two decades of axillary management in breast cancer.Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer.Screening outcome in women repeatedly recalled for the same mammographic abnormality before, during and after the transition from screen-film to full-field digital screening mammography.Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.Patterns of Care in the Administration of Neo-adjuvant Chemotherapy for Breast Cancer. A Population-Based Study.Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study.Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis.
P50
Q26995439-9EBCDD87-1A0F-4C44-A34C-B817E089367EQ30828904-7E01F92C-3679-43E5-875E-952D19E11E25Q33644910-9DCC8D6B-668B-4273-A85E-D91806411C89Q33717807-03C8E1C3-D177-4638-B371-215F3C187506Q33843726-0CD0ADCB-BF70-4BEC-9615-4D1D2FB5E903Q33843822-6EF2B631-3A2A-476E-8496-0F78ED831815Q33854781-32E0AE56-5815-4EB2-93A3-666C8A503666Q35677925-2E8E6A03-0D9A-471D-9963-7D1FCC435BBAQ35843006-C95CE70B-E56B-4822-AF58-6F18FDA00123Q35915758-4B901451-5510-4F05-BA96-5C31243997DEQ35963356-8C0DBD97-6087-4231-8F6D-C6D5BE1DC87EQ36295003-7EB07830-F772-49D1-9025-5ACC9FDE9A65Q36415430-80791F17-537E-4481-BD58-115807957ABDQ36446450-34E7F9DB-409F-4B8E-B91C-49A53A9B4947Q36874017-E838A2DC-A8D3-468D-9309-3B1BBF80C139Q36884357-BFF328A0-CCDA-4BCC-9448-9EE8F0F782CAQ37003278-8C2EE4EE-6929-4FD3-BD64-24F226B71200Q37235581-5FF37779-828C-41A2-9331-FABFED7E3809Q37301836-9523CC75-E826-43A4-A23C-47C939C4C580Q37666919-1A01D2E1-B68A-4C14-B773-2ABD6C3D8717Q37706917-72251B42-68BE-4915-8504-6C2164220AB4Q38015540-EF5B7555-66F8-4C59-8B5D-C9E1F6ECF75FQ38018568-9602EF95-8C68-466A-A7FB-0F59385B89D9Q38076052-8DC10F03-EE6D-4521-BF75-F76E6BF5763DQ38205744-BDA8D4BC-2469-4521-AAF9-B674751B1E4AQ38259456-744AF92D-9549-439C-BD5F-40037BBD7A4FQ38417399-F3FF6B97-DD35-49EF-90C0-0C28D39EA233Q38519641-24AF43E4-83C1-4BA8-A0DB-4849CA1BF9C8Q38537239-EB4D9F0A-B3B3-4715-BAF0-05946513DF41Q38724046-843B0E72-5D55-4F3D-A3CA-06C67D5B52B7Q38857910-C8B4466A-0493-4FEB-827C-ABFCAC2E93A0Q38905173-3012158C-359D-4FF7-AE92-ADB203CD1F40Q38928989-41DAE307-DC95-4E4E-8190-AEC89CE87018Q39740212-CD419EE0-D009-473E-9996-4470892930D5Q39765500-11076405-E54F-42D7-AA5C-EC5ED48B31B0Q39827781-5B06A2AB-7A39-48A2-9D37-F95DAEC6A547Q39946087-4A26DB59-464C-4901-B166-C54A33960E1FQ39980984-2D79CF4E-076A-4C86-B1FB-3A357855EDBAQ40045057-D173575C-CE0F-450D-8273-42D967707765Q40061771-073A701A-9523-4D3F-B47B-8DBB12F06116
P50
description
investigador
@es
researcher
@en
name
Adri C. Voogd
@en
Adri C. Voogd
@nl
type
label
Adri C. Voogd
@en
Adri C. Voogd
@nl
altLabel
Voogd AC
@en
prefLabel
Adri C. Voogd
@en
Adri C. Voogd
@nl
P31
P496
0000-0002-8041-2720